Effect of suplatast tosilate on cough variant asthma

Allergology International

Volumn 49, Issue 1, 2000, Pages 89-92

  Shioya, Takanobu ^a   Kagaya, Manabu ^a   Sano, Masaaki ^a   Ito, Takeshi ^a   Shindo, Tsutomu ^a   Kashima, Masayuki ^a   Watanabe, Akiko ^a   Sato, Kazuhiro ^a   Ito, Nobuaki ^a   Sasaki, Masahiro ^a   Miura, Mamoru ^a  

^a AKITA UNIVERSITY   (Japan)

Author keywords

Asthma; Capsaicin; Cough threshold; Cough variant asthma; Eosinophilic cationic protein; Suplatast; T helper 2 cell derived cytokine inhibitor

Indexed keywords

SUPLATAST TOSYLATE;

ADULT; ARTICLE; ASTHMA; CASE REPORT; CLINICAL FEATURE; COUGHING; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 6744260818     PISSN: 13238930     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1592.2000.00164.x     Document Type: Article

References (20)

1. Glauser FL. Variant asthma. Ann. Allergy 1972; 30: 457-9.
2. Corrao WM, Braman SS, Irwin RS. Chronic cough as the sole presenting manifestation of bronchial asthma. N. Engl. J. Med. 1979; 300: 633-7.
3. Niimi A, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F. Eosinophilic inflammation in cough variant asthma. Eur. Respir. J. 1998; 11: 1064-9.
4. Irwin RS, Boulet L-P, Cloutier MM et al. Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest 1998; 114: S133-81.
5. Yanagihara Y, Kiniwa M, Ikizawa K et al. Suppression of IgE production by IPD-1151T (Suplatast Tosilate), a new dimethylsulfonium agent: (1) Regulation of murine IgE response. Jap. J. Pharmacol. 1993; 61: 23-30.
6. Yanagihara Y, Kiniwa M, Ikizawa K, Shida T, Matsuura N, Koda A. Suppression of IgE production by IPD-1151T (Suplatast Tosilate), a new dimethylsulfonium agent: (2) Regulation of human IgE response. Jap. J. Pharmacol. 1993; 61: 31-9.
7. Iijima H, Tamura G, Hsiue T-R, Liu Y, Taniguchi H, Shirato K. Suplatast tosilate inhibits late response and airway inflammation in sensitized guinea pigs. Am. J. Respir. Care Med. 1999; 160: 331-5.
8. Sano Y, Miyamoto T, Makino S. Anti-inflammatory effect of suplatast tosilate on mild asthma. Chest 1997; 12: 862-3.
9. Takishima T, Hida W, Sasaki H, Suzuki S, Sasaki T. Direct-writing recorder of the dose-response curves of the airway to methacholine, Clinical application. Chest 1981; 80: 600-6.
10. Midgren B, Hansson L, Karlsson J-A, Simonsson BG, Pensson CGA. Capsaicin-induced cough in humans. Am. Rev. Respir. Dis. 1992; 146: 347-51.
11. Shioya T, Ito N, Watanabe A et al. Antitussive effect of azelastine hydrochloride in patients with bronchial asthma. Arzneimittel Forschung/Drug Res. 1998; 48: 149-53.
12. Japanese Society of Allergology, Committee on the definition treatment and management of bronchial asthma. Guidelines for the diagnosis and management of bronchial asthma. Allergy 1995; 50 (Suppl.): 1-41.
13. Pin I, Gibson PG, Kolendowicz R et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47: 25-9.
14. Dor PJ, Ackerman SJ, Gleich GJ. Charcot-Leyden crystal protein and eosinophil granule major basic protein in sputum of patients with respiratory diseases. Am. Rev. Respir. Dis. 1984; 130: 1072-7.
15. Fujimura M, Sakamoto S, Kamio Y, Matsuda T. Cough receptor sensitivity and bronchial responsiveness in normal and asthmatic subjects. Eur. Respir. J. 1992; 5: 291-5.
16. Fujimura M, Kamio Y, Hashimoto T, Matsuda T. Cough receptor sensitivity and bronchial responsiveness in patients with only chronic non-productive cough - in view of effect of bronchodilator therapy. J. Asthma 1994; 31: 463-72.
17. Widdicombe JG. Neurophysiology of the cough reflex. Eur. Respir. J. 1995; 8: 1193-202.
18. Ujiie Y, Sekizawa K, Aikawa T, Sasaki H. Evidence for substance P as an endogenous substance causing cough in guinea pigs. Am. Rev. Respir. Dis. 1993; 148: 1628-32.
19. Tomaki M, Ichinose M, Miura M et al. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am. J. Respir. Crit. Care Med. 1995; 151: 613-17.
20. Tsubura E, Kobayashi S, Makino S et al. Clinical evaluation of IPD-1151T on adult patients with bronchial asthma. Pharmacol. Ther. 1992; 20: 3221-42 (in Japanese).